At a glance
- Originator Taisho Pharmaceutical
- Class Anthracyclines; Antibacterials; Antineoplastics; Antithrombotics
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Thrombosis
Most Recent Events
- 14 Feb 1995 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)